1 asset in Epilepsy Syndrome
Therapeutic assets addressing Epilepsy Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Retigabine Epilepsy Syndrome | Xenon Pharmaceuticals Inc. | P3 | CCC (54) |
Therapeutic assets addressing Epilepsy Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Retigabine Epilepsy Syndrome | Xenon Pharmaceuticals Inc. | P3 | CCC (54) |